Aurobindo Pharma Ltd. Stock Declines by -3.52% on October 1st, Underperforming Market
Aurobindo Pharma Ltd., a major player in the pharmaceuticals and drugs industry, has experienced a -3.52% decline in its stock price on October 1st, 2024. The stock has been on a downward trend for the past four days, with a -7.3% fall. Despite this, the company remains a largecap in its industry.
Aurobindo Pharma Ltd., a leading player in the pharmaceuticals and drugs industry, has seen a decline in its stock price by -3.52% on October 1st, 2024. This underperformance is reflected in the stock's 'Hold' rating by MarketsMOJO.
The stock has been on a downward trend for the past four days, with a fall of -7.3% in this period. On the day of October 1st, the stock touched an intraday low of Rs 1413.65, a decrease of -3.31%. While the stock's performance is higher than its 100-day and 200-day moving averages, it is lower than its 5-day, 20-day, and 50-day moving averages.
In comparison to the overall market performance, Aurobindo Pharma Ltd. has underperformed with a -3.24% return, while the Sensex has only seen a -0.17% decline. Over the past month, the stock has seen a -10.13% decrease, while the Sensex has seen a positive return of 2.17%.
Despite these recent declines, Aurobindo Pharma Ltd. remains a largecap company in the pharmaceuticals and drugs industry. This information is based on facts and does not include any external data or sources. As always, it is important for investors to conduct their own research and make informed decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
